Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.
Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.

This Fund Manager Rating is based on the Citywire Long Only ratings methodology

Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated

Jean Hynes

Jean Hynes

Showing manager performance in Luxembourg View performance globally

About Jean Hynes

Jean Hynes is a global industry analyst and portfolio manager at Wellington Management. She is the sector team leader for the Health Care team in Global Industry Research. As portfolio manager, she manages the Vanguard Healthcare Fund, three global health care hedge funds, and global health care sector portfolios. Jean has spent a large part of her career specializing in the pharmaceutical and biotechnology industries. Jean joined Wellington Management upon her graduation from Wellesley College (1991), where she was awarded a BA in economics. Additionally, she holds the Chartered Financial Analyst designation and is a member of the CFA Institute and the Boston Security Analysts Society.

Are you Jean Hynes?

Citywire Rating: A rated

2014

  • JRated A in Jul 2014
  • ARated A in Aug 2014
  • SRated A in Sep 2014
  • ORated Plus in Oct 2014
  • NRated A in Nov 2014
  • DRated A in Dec 2014

2015

  • JRated AA in Jan 2015
  • FRated AA in Feb 2015
  • MRated AA in Mar 2015
  • ARated AA in Apr 2015
  • MRated AA in May 2015
  • JRated AA in Jun 2015
  • JRated AA in Jul 2015
  • ARated AA in Aug 2015
  • SRated AAA in Sep 2015
  • ORated AA in Oct 2015
  • NRated AAA in Nov 2015
  • DRated AAA in Dec 2015

2016

  • JRated AAA in Jan 2016
  • FRated AA in Feb 2016
  • MRated AA in Mar 2016
  • ARated AA in Apr 2016
  • MRated AA in May 2016
  • JRated AAA in Jun 2016
  • JRated AA in Jul 2016
  • ARated AA in Aug 2016
  • SRated AA in Sep 2016
  • ORated AA in Oct 2016
  • NRated AA in Nov 2016
  • DRated AA in Dec 2016

2017

  • JRated AA in Jan 2017
  • FRated AA in Feb 2017
  • MRated AA in Mar 2017
  • ARated AA in Apr 2017
  • MRated AAA in May 2017
  • JRated AA in Jun 2017
  • JRated AA in Jul 2017
  • ARated AA in Aug 2017
  • SRated AA in Sep 2017
  • ORated AA in Oct 2017
  • NRated A in Nov 2017
  • DRated A in Dec 2017

Performance

Equity - Pharmaceuticals & Health Care
over : 30/11/2016 - 30/11/2017

Total Return

Month by Month Performance

Quarterly Performance

to 30/09/2017 Annual Q1 Q2 Q3 Q4
2017 11.1% 0.4% -1.7%
2016 -7.3% -17.5% 8.5% 4.0% -0.5%
2015 27.7% 23.5% 0.7% -10.1% 14.3%
2014 45.4% 8.7% 5.2% 8.5% 17.3%
2013 41.9% 19.2% 3.0% 6.0% 9.1%

Related News

Sector showdown: fighting fit in pharma

Leading the pack in pharma, Citywire Selector delves into the data.

Citywire Discovery Source: Citywire Discovery Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated)..Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.